ARCHIVES

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

This article is from The Cancer Letter archive.

Vol. 22 No. 14 | April 4, 1996

Download PDF Visit The Full Archive

Related Articles

Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million

April 12, 1985

Technology Isolates and Recovers Circulating Liver Tumor Cells

April 27, 2012

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987